UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           Washington, D. C. 20549
                                 FORM 10-QSB


(x )   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the quarterly period ended       March  31,  2001
                                 --------------------------

(  )   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the transition period from________________to____________________________

Commission File number   000-26119
                       --------------

                        ALTRIMEGA  HEALTH  CORPORATION
              -------------------------------------------------
              (Exact name of registrant as specified in charter)

            Nevada                               87-0631750
--------------------------------               -----------------
(State or other jurisdiction of                (I.R.S. Employer
incorporation or organization)                 Identification No.)

 3672 East Cove Point Drive,  Salt Lake City, Utah        84109
---------------------------------------------------     ---------
(Address of principal executive offices)               (Zip Code)

                                1- 801-278-8000
                        ------------------------------
              Registrant's telephone number, including area code


            ------------------------------------------------------
            (Former name, former address, and former fiscal year,
                        if changed since last report.)

     Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports),  Yes [x ]  No [  ] and (2) has
been subject to such filing requirements for the past 90 days. Yes [x ] No [ ]

                    APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date

            Class                      Outstanding as of March 31, 2001
    ------------------------          ----------------------------------
     Common  Stock, $0.001                    22,020,000


                                     -1-
<PAGE>


                                    INDEX

                                                                         Page
                                                                       Number
PART I.

    ITEM 1. Financial Statements (unaudited)............................... 3

            Balance Sheets ................................................ 4
             March 31, 2001 and June 30, 2000

            Statements of Operations
             Three months ended March 31, 2001  and 2000................... 5
             and the period from September 8, 1998 to March 31, 2001

            Statements of Cash Flows
             Three months ended March 31, 2001 and 2000 ................... 6
             and the period from September 8, 1998 to March 31, 2001

            Notes to Financial Statements.................................. 7

    ITEM 2. Management's Discussion and Analysis or Plan of Operations.... 10

PART II.    Other Information............................................. 11

            Signatures ................................................... 11

                                     -2-

<PAGE>


PART I - FINANCIAL INFORMATION

------------------------------------------------------------------------------

                         ITEM 1. FINANCIAL STATEMENTS

------------------------------------------------------------------------------


The accompanying  balance sheets of Altrimega Health Corporation (development
stage company) at March 31, 2001 and December 31, 2000, and the statements of
operations and cash flows for the three   months ended March 31, 2001 and 2000
and the period from September 8, 1998  to March 31, 2001,  have been prepared
by the Company's management and they do not include all information and notes
to the financial statements necessary for a complete presentation of the
financial position, results of operations, cash flows, and stockholders'
equity in conformity with generally accepted accounting principles.  In the
opinion of management, all adjustments considered necessary for a fair
presentation of the results of operations and financial position have been
included and all such adjustments are of a normal recurring nature.

Operating  results for the quarter ended March 31, 2001, are not necessarily
indicative of the results that can be expected for the year ending December
31, 2001.

                                     -3-

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                                BALANCE SHEETS
                     March 31, 2001 and December 31, 2000

==============================================================================



                                                        Mar 31,      Dec 31,
                                                         2001         2000
                                                    ------------- -----------
ASSETS
CURRENT ASSETS
  Cash                                              $      1,056  $       33
                                                    ------------- -----------
   Total Current Assets                                    1,056          33
                                                    ------------- -----------

PROPERTY AND EQUIPMENT - net of accumulated                1,926       2,066
   depreciation - note 2                            ------------- -----------

ADVANCED DEPOSITS                                         20,000           -
                                                    ------------- -----------

                                                    $     22,982  $    2,099
                                                    ============= ===========

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Note payable and accrued interest payable -       $     38,163  $    5,400
   related party - note 3
  Accounts payable                                           700       1,500
                                                    ------------- -----------
   Total Current Liabilities                              38,863       6,900
                                                    ------------- -----------
STOCKHOLDERS' EQUITY
  Preferred stock
    10,000,000 shares authorized at $0.001 par
    value; none outstanding                                    -           -

  Common stock 50,000,000 shares authorized at
    $0.001 par value; 22,020,000 shares issued and
    outstanding                                           22,020      22,020

  Capital in excess of par value                          74,980      74,980

  Deficit accumulated during the development stage      (112,881)   (101,801)
                                                    ------------- -----------

   Total Stockholders' Deficiency                        (15,881)     (4,801)
                                                    ------------- -----------

                                                    $     22,982  $    2,099
                                                    ============= ===========


  The accompanying notes are an integral part of these financial statements.

                                     -4-




<PAGE>


                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENTS OF OPERATIONS
         For the Three Months Ended March 31, 2001 and 2000 and the
        Period September 8, 1998 (Date of Inception) to March 31, 2001

==============================================================================


                                        Mar 31,      Mar 31,   Sept 8, 1998 to
                                         2001         2000     Mar. 31, 2001
                                     ------------ ------------ --------------

REVENUES                             $         -  $     1,075  $       9,703
                                     ------------ ------------ --------------
EXPENSES

  Product development                      8,000                      64,692
  Administrative                           2,940       16,280         57,018
  Depreciation                               140                         874
                                     ------------ ------------ --------------

                                          11,080       16,280        122,584
                                     ------------ ------------ --------------

NET LOSS                             $   (11,080) $   (15,205) $    (112,881)
                                     ============ ============ ==============

NET LOSS PER COMMON SHARE
  Basic                              $         -  $         -
                                     ------------ ------------
AVERAGE OUTSTANDING SHARES
  Basic                               20,504,000   20,504,000
                                     ------------ ------------




The accompanying notes are an integral part of these financial statements.

                                     -5-
<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENT OF CASH FLOWS
      For the Three Months Ended March 31, 2001 and 2000 and the Period
          September 8, 1998 (Date  of  Inception) to March 31, 2001

==============================================================================


                                        Mar 31,      Mar 31,   Sept 8, 1998 to
                                         2001         2000     Mar. 31, 2001
                                     ------------ ------------ --------------
CASH FLOWS FROM OPERATING ACTIVITIES

  Net loss                           $   (11,080) $   (15,205) $    (112,881)

   Adjustments to reconcile net loss
   to net cash provided by operating
   activities

    Depreciation                             140        3,432            874
    Changes in accounts payable           31,963            -         38,863
                                     ------------ ------------ --------------
     Net Cash Received (Used)
     in Operations                        21,023      (11,773)       (73,144)
                                     ------------ ------------ --------------

CASH FLOWS FROM INVESTING ACTIVITIES

  Purchase of equipment                        -            -         (2,800)
  Advance deposit - lease                (20,000)           -        (20,000)
                                     ------------ ------------ --------------
                                         (20,000)           -        (22,800)
                                     ------------ ------------ --------------
CASH FLOWS FROM FINANCING ACTIVITIES

  Proceeds from issuance of
   common stock                                -       15,000         97,000
                                     ------------ ------------ --------------

 Net Increase (decrease) in Cash           1,023        3,227          1,056

 Cash at Beginning of Period                  33        4,125              -
                                     ------------ ------------ --------------

 Cash at End of Period               $     1,056  $     7,352  $       1,056
                                     ============ ============ ==============






  The accompanying notes are an integral part of these financial statements.

                                     -6-
<PAGE>



                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                        NOTES TO FINANCIAL STATEMENTS

==============================================================================

1.     ORGANIZATION

The Company was incorporated under the laws of the State of Nevada on
September 8, 1998 with the name of  Mega  International  Health  Corporation
with authorized common stock of 50,000,000 shares with a par value of $0.001
and preferred stock of 10,000,000 shares with a par value of $0.001. The board
of directors will determine the powers and rights of the preferred stock when
it is issued. On June 23, 1999 the name was changed to Altrimega Health
Corporation. On March 19,2001 the Company   completed a forward common stock
split of four shares for each outstanding share.  This report has been
completed showing after stock split shares from inception.

The Company was organized for the purpose of marketing nutritional products.

The Company is in the development stage.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Methods
------------------

The Company recognizes income and expenses based on the accrual method of
accounting.

Dividend Policy
---------------

The Company has not  adopted a policy regarding payment of dividends.

Property and Equipment
----------------------

The equipment consists of office furniture and equipment which is being
depreciated over 5 years.

Income Taxes
------------

On March 31, 2001 the Company had a net operating loss carryforward of
$112,881. The  tax benefit of $33,864 from the loss carry forward  has been
fully offset by a valuation reserve because the use of the future tax benefit
is doubtful, since the Company has no operations on which to project  future
net profits.

The loss carryover will expire in 2022.

Financial Instruments
---------------------

The carrying amounts of financial instruments, including cash, property and
equipment, and accounts payable,  are considered by management to be their
estimated fair values.

                                     -7-
<PAGE>


                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

==============================================================================

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Basic and Diluted Net Income (Loss) Per Share
---------------------------------------------

Basic net income (loss) per share amounts are computed based on the weighted
average number of shares actually outstanding. Diluted net income (loss) per
share amounts are computed using the weighted average number of common shares
and common equivalent shares outstanding as if shares had been issued on the
exercise of the preferred share rights unless the  exercise becomes
antidilutive and then only the basic per share amounts are shown in the
report.

Estimates and Assumptions
--------------------------

Management uses estimates and assumptions in preparing financial statements in
accordance with generally accepted accounting principles.  Those estimates and
assumptions affect the reported amounts of the assets and liabilities, the
disclosure of contingent assets and liabilities, and the reported revenues and
expenses.  Actual results could vary from the estimates that were assumed in
preparing these financial statements.

Comprehensive Income
--------------------

The Company has adopted Statement of Financial Accounting Standards No. 130.
The adoption of this standard had no impact on the total stockholder's equity.

Other Recent Accounting Pronouncements
---------------------------------------

The Company does not expect that the adoption of other recent accounting
pronouncements to have any material impact on its  financial statements.

3.  NOTE PAYABLE

The note payable consists of  a  no interest, demand loan, received from a
related party. Imputed interest at 8% has been included.

4.  RELATED PARTY TRANSACTIONS

70% of the outstanding common stock  was issued to a related parties.


                                     -8-

<PAGE>


                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

==============================================================================

5.  GOING CONCERN

The company will need additional working capital to service its debt and for
its future  planned activity and continuation of the Company  as a going
concern is dependent upon obtaining sufficient  working capital to be
successful in  that effort and the management of the Company has developed a
strategy, which it believes will accomplish this objective through additional
equity funding, and long term financing, which will enable the Company to
operate for the coming year.


                                     -9-

<PAGE>

------------------------------------------------------------------------------

     ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

------------------------------------------------------------------------------

Overview
--------

The Company's plan of operation focuses on products which have been designed
as a result of the belief its natural medicines and nutritional supplements
offer a better alternative to traditional nutritional supplements currently
being produced by providing specialized combinations of nutrients. Prior to
the formation of Altrimega Health Corporation, an officer of the Company
completed the development of the Company's initial product line, and has
established relationships with suppliers of the various nutrients comprising
the Altrimega Health products. Additionally, the Company has established a
relationship with a Utah "contract" manufacturer, which will provide the
Company with product manufacturing, bottling and packaging.

The Company is now seeking to establish a distributor network with marketing
firms involved in the nutritional supplement industry throughout the country.
The Company also plans to undertake efforts to market its products through the
internet, various retail markets, including health food stores, and direct
sales through a toll-free number.

Proposed Activities
-------------------

As soon as is reasonably practicable, the Company plans to complete the
manufacturing and  distributing arrangements with  selected brokers in the
industry, in different regions of the country. At the same time, the Company
will continue with efforts to directly market its products to other retail
markets. To the extent the Company's funds allow, the Company will develop and
market additional nutritional products, to meet different special health needs
and niche markets.

Liquidity and Capital Resources
-------------------------------

As of March 31, 2001, the Company did not have sufficient  assets to pay its
liabilities.

Results of Operations
---------------------

The Company is a development stage company and   had no operations during the
quarter ended March 31, 2001.

Liquidity and Capital Resources
-------------------------------

The Company will need additional working capital  to finance its planned
activity.


                                     -10-
<PAGE>



PART II - OTHER INFORMATION


                             PART 2 - SIGNATURES

------------------------------------------------------------------------------

                                  SIGNATURES

------------------------------------------------------------------------------

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned there unto duly authorized.


                                    Altrimega Health Corporation
                                    [Registrant]


                                    /s/ Howard Abrams
                                    ----------------------------------
                                        Howard Abrams - President
Dated May 3, 2001





                                     -11-